Skip to main content

Clinical Trial Results


Dr. Julian Gillmore, Dr. David Lebwohl, and Dr. C. Michael Gibson Discuss: First-in-Human in vivo Crispr/Cas9 Editing of the Ttr Gene by Ntla-2001 in Patients with Transthyretin Amyloidosis With Cardiomyopathy

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab


Disclosures: TBA